Similarly, age-related striatal DAT decline does not seem to be exaggerated or accelerated in PD [114], even though activation of regulatory and compensatory mechanisms directed at maintaining DA uptake, superimposed upon disease-related DA terminal loss, may have masked significant age correlations [115,116] (Figure 1). This evidence concerns the gene SLC6A3 and Parkinson disease.